Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001837749 | SCV000284764 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000247365 | SCV000303940 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Cardiovascular Research Group, |
RCV000203119 | SCV000322839 | benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | 1Hmz + 1Htz/88 non-FH individuals |
Illumina Laboratory Services, |
RCV001094639 | SCV000427110 | likely benign | Hypercholesterolemia, autosomal dominant, type B | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Laboratory for Molecular Medicine, |
RCV000247365 | SCV000538312 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: High frequency |
Laboratory of Genetics and Molecular Cardiology, |
RCV000203119 | SCV000588427 | benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Gene |
RCV000247365 | SCV000729922 | benign | not specified | 2017-06-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Iberoamerican FH Network | RCV000203119 | SCV000748123 | benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Robarts Research Institute, |
RCV000203119 | SCV000782839 | likely benign | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771075 | SCV000902608 | benign | Familial hypercholesterolemia | 2017-06-13 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000227119 | SCV001133404 | benign | not provided | 2022-01-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000227119 | SCV002047756 | likely benign | not provided | 2024-08-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000227119 | SCV002544004 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | APOB: BP4, BS2 |
Ambry Genetics | RCV002321801 | SCV002605691 | benign | Cardiovascular phenotype | 2016-03-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genomic Diagnostic Laboratory, |
RCV000203119 | SCV000257679 | uncertain significance | Hypercholesterolemia, familial, 1 | 2015-03-06 | flagged submission | clinical testing | |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000247365 | SCV000605974 | pathogenic | not specified | flagged submission | research | ||
Clinical Genetics, |
RCV000247365 | SCV001919982 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000227119 | SCV001963451 | likely benign | not provided | no assertion criteria provided | clinical testing |